Resistance to targeted therapies in breast cancer
We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signaling pathways aberrantly activated in triple negative breast can...
Saved in:
| Other Authors | |
|---|---|
| Format | Electronic eBook |
| Language | English |
| Published |
Cham, Switzerland :
Springer,
[2017]
|
| Series | Resistance to targeted anti-cancer therapeutics ;
v. 16. |
| Subjects | |
| Online Access | Full text |
| ISBN | 9783319701424 9783319701417 |
| ISSN | 2196-551X ; |
| Physical Description | 1 online resource |